In QuotedData’s morning briefing 16 May 2024:
- Polar Capital Global Healthcare (PCGH) says that at end March 2024, its six-month NAV returns were seven percentage points better than its benchmark’s (16.55% versus 9.56% for MSCI ACWI/Healthcare Index). The manager says that this was driven by strong stock selection across the entire market capitalisation range and the majority of geographies. Stocks that contributed positively to the relative performance over the period included Zealand Pharma, UnitedHealth Group, DexCom, UCB and Pfizer. The discount narrowed a little from 7.7% to 6.7%. [QD comment: Great shorter-term returns like these mean that the trust continues to pull ahead of the competition. Over the longer-term (3 and 5 years), the trust’s returns are now well-ahead of peers.]